Dmitry Balyasny’s CME Group CME Stock Holding History

Dmitry Balyasny’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.27M	Buy	+14,800	New	+$4.09M	﹤0.01%	1580
2026 Q1	–	Sell	-4,700	Closed	-$1.28M	–	2963
2025 Q4	$1.28M	Buy	4,700 +2,000	+74%	+$543K	﹤0.01%	2073
2025 Q3	$730K	Sell	2,700 -1,500	-36%	-$408K	﹤0.01%	2243
2025 Q2	$1.16M	Sell	4,200 -3,600	-46%	-$979K	﹤0.01%	1994
2025 Q1	$2.07M	Sell	7,800 -200	-3%	-$49.3K	﹤0.01%	1686
2024 Q4	$1.86M	Sell	8,000 -157,000	-95%	-$36.1M	﹤0.01%	1694
2024 Q3	$36.4M	Buy	+165,000	New	+$34.1M	0.06%	415
2023 Q1	–	Sell	-29,400	Closed	-$4.94M	–	2711
2022 Q4	$4.94M	Hold	29,400	–	–	0.01%	1039
2022 Q3	$5.21M	Buy	29,400 +21,900	+292%	+$4.33M	0.02%	969
2022 Q2	$1.53M	Buy	+7,500	New	+$1.59M	0.01%	1547

Other funds holding CME

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Dmitry Balyasny's CME Position: Q2 2026 in Review

Dmitry Balyasny reduced its CME Group (CME) stake by 85% in Q2 2026, selling an estimated $109M and leaving 70,710 shares worth $15.6M. The position accounts for 0.02% of the portfolio, ranked #841.

Dmitry Balyasny first reported a position in CME in Q2 2013 and has held it in 52 quarters since. The position peaked at $284M in Q3 2024. 1,694 funds tracked by Wall St. Rank hold CME as of Q2 2026.

Dmitry Balyasny held 70,710 shares of CME Group worth $15.6M as of Q2 2026.
Dmitry Balyasny sold 393,914 CME Group shares in Q2 2026, an estimated $109M.
CME Group made up 0.02% of Dmitry Balyasny's portfolio in Q2 2026, its #841 holding.
Dmitry Balyasny first reported a position in CME Group in Q2 2013 and has held it in 52 quarters since.
Dmitry Balyasny's CME Group position peaked at $284M in Q3 2024.
1,694 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.